The Procter & Gamble Company (PG) — Fundamental Analysis

Procter & Gamble is one of the most financially consistent consumer staples businesses on the planet. Revenue has grown steadily from roughly $70 billion in 2020 to $87 billion in fiscal 2026, while operating margins have held in the 22–24% range and net margins have stayed close to 18–19% in most years. The balance sheet carries a moderate debt load, capex spending is disciplined and rising gradually in line with the business, and the company generates substantial earnings even after reinvestment. The one notable blemish in the record is fiscal 2019, when a large non-cash impairment charge depressed reported margins sharply — that was a one-time accounting event rather than an operational deterioration. In plain terms: P&G is a slow-and-steady compounder that prioritizes consistent profitability and cash generation over explosive growth, making it a textbook defensive holding.

Snapshot & Big Picture

P&G sells household brands — Tide, Pampers, Gillette, Oral-B, Dawn — across more than 180 countries. Its scale gives it significant pricing power and distribution advantages that are difficult for smaller competitors to replicate. The business is not built for rapid revenue growth; instead, it earns its keep by extracting consistently high margins from a large and relatively stable revenue base, returning capital to shareholders through dividends and buybacks. Fiscal year 2026 (ended June 30, 2026) marked another year of mid-single-digit revenue growth paired with operating margins above 22%, continuing a well-established pattern.

Latest Quarter Snapshot

The most recent quarterly data (the quarter ended June 30, 2026, derived from the fiscal year 2026 10-K filing) is the most current view of the business. Revenue for the quarter came in at $21.2 billion, with EBITDA of $4.8 billion. Operating margin of 18.6% and net margin of 14.4% were softer than the full-year annual averages, which is not unusual for a single quarter and may reflect seasonal mix, timing of expenses, or cost pressures in a specific period. Gross margin data was not available in the filing for this period. Capital expenditures in the quarter were $1.0 billion, representing 4.8% of quarterly revenue, consistent with the annual capex intensity trend. The current ratio stood at 0.68 and the debt-to-equity ratio at 0.54, matching the full-year figures as expected.

Profitability

Excluding the anomalous fiscal 2019 (when a large impairment charge collapsed reported margins to 8.1% operating and 5.8% net), P&G's profitability record is remarkably stable. Operating margins have ranged from approximately 20% to 24% over the past decade, and net margins have consistently tracked in the 17–19% band since 2020. Fiscal 2025 saw the strongest operating margin in the dataset at 24.3%, suggesting pricing actions and cost efficiencies were working well that year. Fiscal 2026 moderated slightly to 22.7% — still well within the historical comfort zone. EBITDA has grown from $18.7 billion in 2020 to $22.9 billion in 2026, a meaningful absolute expansion driven by both volume growth and operating leverage. The fiscal 2017 net margin of 23.6% was elevated by one-time tax or accounting items and should be read as an outlier on the high side, just as 2019 was on the low side.

Financial Health

P&G's balance sheet reflects a well-managed, investment-grade business. The debt-to-equity ratio has stayed in a tight range of roughly 0.35 to 0.60 over the past decade, creeping up modestly from 0.35 in 2017 to about 0.54–0.58 more recently, but never reaching a level that would signal financial stress. The current ratio has consistently sat below 1.0 (ranging from 0.63 to 0.88), which in isolation sounds concerning but is entirely normal for a large consumer staples company with strong, predictable operating cash flows — P&G has no difficulty meeting near-term obligations despite technically having more current liabilities than current assets.

Capital Expenditures: Capex has grown steadily in dollar terms, from $2.8 billion in fiscal 2021 to $4.4 billion in fiscal 2026, reflecting ongoing investment in manufacturing capacity and supply chain infrastructure. However, as a percentage of revenue, capex intensity has remained quite stable — hovering between roughly 3.7% and 5.6% over the full period, and more tightly in the 3.9%–5.1% range in recent years. The fiscal 2026 figure of 5.1% of revenue is modestly above the trough of 3.7% seen in fiscal 2021, suggesting P&G is in a mild acceleration phase of reinvestment, but capital intensity remains low by industrial standards. This is a hallmark of the consumer staples model: relatively modest reinvestment requirements relative to the earnings the business generates.

Growth

P&G is not a high-growth company, and the CAGR figures confirm that clearly. Recent top-line growth has been modest — roughly 2% annually over the past three years. The five-year rate is slightly better at 2.7%, reflecting stronger post-pandemic volume and pricing tailwinds in 2021–2022. The ten-year CAGR of 11.5% is a statistical artifact and should not be taken at face value: the fiscal 2014 entry in the dataset shows revenue of only $29.4 billion, which is far below what the full P&G business was generating at that time and likely reflects a partial-year or segment-level filing rather than consolidated revenue — meaning the ten-year CAGR is not a meaningful measure of the company's actual long-run growth rate.

The 3- and 5-year CAGRs tell a consistent story: P&G grows revenue in the low-single digits, supported primarily by pricing rather than volume expansion in recent years. For a company of this scale and maturity, that pace is appropriate — investors in P&G are generally seeking stability, dividend income, and margin quality rather than aggressive top-line growth.

Source Filings

• 10-K filed August 4, 2026 (Fiscal Year Ended June 30, 2026)
• 10-Q filed April 24, 2026 (Quarter Ended March 31, 2026)